A1/A2 polymorphism of glycoprotein IIIa and association with excess procedural risk for coronary catheter interventions: A case-controlled study

Lancet

Volumn 353, Issue 9154, 1999, Pages 708-712

  Laule, Michael ^a   Cascorbi, Ingolf ^b   Stangl, Verena ^a   Bielecke, Claudia ^a   Wernecke, Klaus D ^c   Mrozikiewicz, Przemyslaw M ^b   Felix, Stephan B ^a   Roots, Ivar ^b   Baumann, Gert ^a   Stangl, Karl ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b Inst F Klin Pharmakol Toxikol   (Germany)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN IIIA;

ADULT; AGED; ALLELE; ANGIOCARDIOGRAPHY; ARTICLE; ATHERECTOMY; ATHEROGENESIS; CASE CONTROL STUDY; CATHETERIZATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DILATATION; CORONARY ARTERY DISEASE; CORONARY ARTERY SURGERY; CORONARY STENT; FEMALE; GENETIC POLYMORPHISM; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; STATISTICAL ANALYSIS; SURGICAL RISK;

EID: 0033608386     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(98)07257-2     Document Type: Article

References (19)

1. Bennett JS. The molecular biology of platelet membrane proteins. Semin Hematol 1990; 27: 186-204.
2. Nurden AT, Nurden P. A review of the role of platelet membrane glycoproteins in the platelet-vessel wall interaction. Bailliere's Clin Haematol 1993; 6: 653-90.
3. Nurden AT. Platelet glycoprotein Ilia polymorphism and coronary thrombosis. Lancet 1997; 350: 1189-90.
4. Nurden AT. Polymorphisms of human platelet membrane glycoproteins: structure and clinical significance. Thromb Haemost 1995; 74: 345-51.
5. Walter DH, Schächinger V, Elsner M, Dimmeler S, Zeiher AM. Platelet glycoprotein Ilia polymorphisms and risk of coronary stent thrombosis. Lancet 1997; 350: 1217-19.
6. A polymorphism in young men with myocardial infarction. Lancet 1996; 348: 485-86.
7. Weiss EJ, Bray PF, Tayback M, et al. A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis. N Engl JMed 1996; 334: 1090-94.
8. A2) of the glycoprotein IIIa (GPIIIa) receptor is not related to myocardial infarction in the ECTIM Study. Thromb Haemost 1997; 77: 1179-81.
9. A1/A2 polymorphism of platelet glycoprotein Ilia and risks of myocardial infarction, stroke, and venous thrombosis. Lancet 1997; 349: 385-88.
10. Nomenclature and criteria for diagnosis of ischemic heart disease. Report of the Joint International Society and Federation of Cardiology/World Health Organization Task Force on Standardization of Clinical Nomenclature. Circulation 1979; 59: 607-09.
11. Ryan TJ, Bauman WB, Kennedy W, et al. Guidelines for percutaneous transluminal coronary angioplasty: AHA Medical/Scientific Statement - a report of the American Heart Association/American College of Cardiology Task Force on assessment of diagnostic and therapeutic cardiovascular procedures (Committee on Percutaneous Transluminal Coronary Angioplasty). Circulation 1993; 88: 2987-3007.
12. Baim DS, Cutlip DE, Sharma SK, et al for the BOAT investigators. Final results of the Balloon vs Optimal Atherectomy Trial (BOAT). Circulation 1998; 97: 322-31.
13. Fitzgerald LA, Steiner B, Rail SC Jr, Lo SS, Phillips DR. Protein sequence of endothelial glycoprotein IIIa derived from a cDNA clone: identity with platelet glycoprotein Ilia and similarity to 'integrin'. J Biol Chem 1987; 262: 3936-39.
14. King III SB, Yeh W, Holubkov R, et al for the NHLBI and NACI Registry Investigators. Balloon angioplasty versus new device intervention: clinical outcomes - a comparison of the NHLBI and NACI registries. J Am Coll Cardiol 1998; 31: 5558-66.
15. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. N Engl J Med 1996; 335: 217-25.
16. King III SB, Lembo NJ, Weintraub WS, et al. A randomised trial comparing coronary angioplasty with coronary bypass surgery: emory angioplasty versus surgery trial (EAST). N Engl J Med 1994; 331: 1044-50.
17. Schoemig A, Neumann FJ, Kastrati A, et al. A randomized comparison of antiplatelet and anticoagulant therapy after placement of coronary-artery stents. N Engl J Med 1996; 334: 1084-89.
18. Serruys PW, Emanuelson H, van der Giessen W, et al. Heparin-coated Palmaz-Schatz stents in human coronary arteries: early outcome of the Benestent II pilot study. Circulation 1996; 93: 412-22.
19. A polymorphism of glycoprotein IIb/IIIa and the fibrinogen Bβ 448 polymorphism with myocardial infarction and extent of coronary artery disease. Circulation 1997; 96: 1424-31.